Gonzague Issenmann

Gonzague Issenmann is an accomplished executive with extensive leadership experience in the medical technology sector. As the co-founder, Executive Chairman, and CEO of Womed since February 2018, Gonzague focuses on addressing challenging uterine pathologies faced by women. In addition to this role, Gonzague serves on the board of directors for multiple companies, including AcuSurgical, Sim&Cure, and Sensome, and has held prominent positions such as CEO of STENTYS, where Gonzague co-founded and led the development of Self-Apposing® stent technology for coronary disease, overseeing its growth to IPO. Gonzague's career is further enriched by roles at Johnson & Johnson and Faurecia, alongside a solid educational background with an MBA from INSEAD and a Master’s degree in Robotics from CentraleSupélec.